Form D · Biotechnology

Hamilton Thorne Ltd.

Beverly, MA · CIK 0001551146

Offering snapshot reported Oct 13, 2017 · SEC filing

Reported sold
$150K
Offering amount: $150K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 28, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2017Initial$150,000No comparison1SEC filing
May 10, 2017Initial$9,153,485No comparison21SEC filing
Jun 24, 2015Initial$1,227,633No comparison17SEC filing
Nov 19, 2014Initial$660,659No comparison16SEC filing
May 31, 2012Initial$349,895No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-296620
Total Offering Amount and Total Amount Sold converted from C$186,750 as of September 28, 2017.

Source: Form D, filed Oct 13, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Bruns Executive
Diarmaid H. Douglas Hamilton Director, Executive
Dean Gendron Director
Bruno Maruzzo Director
Robert Potter Director
David Sable Director
Meg Spencer Director
Daniel Thorne Director
David Wolf Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
100 Cummings Center Suite 465 E
Beverly, MA, 01915